CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thulasi, R.
Right arrow Articles by Houghton, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thulasi, R.
Right arrow Articles by Houghton, J. A.

Cell Growth & Differentiation, Vol 7, Issue 4 531-541, Copyright © 1996 by American Association of Cancer Research


ARTICLES

Alpha 2a-interferon-induced differentiation of human alveolar rhabdomyosarcoma cells: correlation with down-regulation of the insulin-like growth factor type I receptor

R Thulasi, P Dias, PJ Houghton and JA Houghton
Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101, USA.

Rhabdomyosarcoma, a tumor of skeletal muscle origin, appears developmentally arrested at an early stage in the myogenic differentiation pathway. The proliferation of an alveolar rhabdomyosarcoma cell line Rh30 is dependent on the insulin-like growth factor (IGF) II/IGF-I receptor (IGF-IR) signaling pathway and is highly sensitive to recombinant human IFN-alpha 2a, which induces growth arrest and differentiation of these malignant myoblasts. IFN-alpha 2a-induced growth arrest of Rh30 cells was observed within 48 h, and reduction in colony formation was obtained with an IC50 of 0.81 IU/ ml for 72 h exposure. Down-regulated expression of IGF-IR was apparent by 24 h after initiation of IFN-alpha 2a treatment. Furthermore, an initial increase followed by reduced expression of MyoD, in concert with elevated expression of myogenin, increased frequency of skeletal muscle myosin-positive cells, and the formation of multinucleated cells, indicated an enhancement of differentiation of Rh30 cells in the presence of IFN-alpha 2a. To probe the role of IGF-IR in the differentiation of Rh30 cells along the myogenic lineage, the effect of antisense RNA-mediated reduction of endogenous IGF-IR on growth and expression of muscle-specific proteins was determined. Rh30 cells transfected to stably express antisense IGF-IR (clone AS [symbol: see text] 23)showed significant reduction in growth rate, decreased expression of IGF-IR protein, increased expression of MyoD, myosin heavy chain, and an increased number of multinucleated cells in comparison to the parental line. These data are consistent with overexpression of IGF-IR inhibiting differentiation. IFN-alpha 2a treatment of AS [symbol: see text] 23 cells further induced both MyoD and myogenin expression, thereby allowing cells to proceed further downstream of the differentiation pathway.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
R. Bagatell, C. E. Herzog, T. M. Trippett, J. F. Grippo, G. Cirrincione-Dall, E. Fox, M. Macy, J. Bish, P. Whitcomb, A. Aikin, et al.
Pharmacokinetically Guided Phase 1 Trial of the IGF-1 Receptor Antagonist RG1507 in Children with Recurrent or Refractory Solid Tumors
Clin. Cancer Res., February 1, 2011; 17(3): 611 - 619.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. Vitale, P. M. van Koetsveld, W. W. de Herder, K. van der Wansem, J. A. M. J. L. Janssen, A. Colao, G. Lombardi, S. W. J. Lamberts, and L. J. Hofland
Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells
Am J Physiol Endocrinol Metab, March 1, 2009; 296(3): E559 - E566.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Takemoto, H. Yano, S. Momosaki, S. Ogasawara, N. Nishida, S. Kojiro, T. Kamura, and M. Kojiro
Antiproliferative Effects of Interferon-{alpha}Con1 on Ovarian Clear Cell Adenocarcinoma In vitro and In vivo
Clin. Cancer Res., November 1, 2004; 10(21): 7418 - 7426.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
P. L. Puri, Z. Wu, P. Zhang, L. D. Wood, K. S. Bhakta, J. Han, J. R. Feramisco, M. Karin, and J. Y.J. Wang
Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells
Genes & Dev., March 1, 2000; 14(5): 574 - 584.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1996 by the American Association of Cancer Research.